Morgan Moncada
CEO, Neru Health
Bio: Morgan Moncada is the CEO and co-founder of Neru Health, which is on a mission to scale sleep and medical device healthcare. Morgan has more than a decade of life science startup experience, managing business development, operations, and product teams at therapeutics and synthetic biology startups. He brings his perspective as a sleep apnea and insomnia patient struggling to access and navigate care to his work at Neru. Morgan received his BS Biology at Stanford and MBA and MS Biotechnology at Harvard.
Org Info: Neru Health is an AI-powered care automation platform helping clinics and medical device suppliers support patients with chronic conditions like sleep apnea and diabetes. Our AI assistant manages patients and clinical/resupply workflows 24/7 to improve diagnosis completion, treatment adherence, and resupply, reducing the need for costly human labor. By bridging fragmented handoffs between primary care, diagnostics, and ongoing therapy, we enable better outcomes for underserved and overlooked patients. Our founders live with these conditions and built Neru to close the care gaps we personally experienced.
What motivated you to pursue your current work? (i.e., What is your “why”?)
I suffered for years with insomnia and sleep apnea, going through multiple diagnostic tests but receiving no follow-up care, no coaching, and no clear path forward. This left me exhausted, anxious, and desperate for solutions. I realized that millions of others—especially shift workers, caregivers, immigrants, and low-income patients—were falling through the same cracks. I started Neru to ensure no one else would have to navigate chronic conditions like sleep apnea or diabetes alone and confused. Our AI platform exists to fill the gaps I personally experienced—providing continuous, compassionate support that extends beyond diagnosis and empowers patients to actually succeed in their care.
What distinct value does your work bring to the digital health field?
Neru delivers end-to-end automation for device-based chronic care—combining AI, behavioral science, and data integration to manage adherence, resupply, and engagement across conditions like sleep apnea and diabetes. Unlike point solutions, we embed directly into DME and clinic workflows, replacing fragmented, manual support systems with 24/7 AI-driven care. Our lived-experience-informed design improves access and outcomes for underserved populations, while unlocking new reimbursement pathways through RTM/RPM codes. Neru’s platform is uniquely positioned to scale personalized care without scaling headcount.
How does your work impact your target end-users or stakeholders?
Our work gives patients with chronic conditions—like sleep apnea, insomnia, and diabetes—24/7 access to personalized support through voice and text AI. We help them overcome common barriers like confusion, stigma, missed follow-ups, and therapy dropouts. For providers and medical device suppliers, we automate high-volume tasks like resupply, coaching, and troubleshooting, reducing staff burden and improving adherence rates. This dual impact improves health outcomes for patients who often feel forgotten, while unlocking new revenue and operational efficiency for our partners. We bring consistency, empathy, and clarity to a care journey that’s often fragmented and overwhelming.
What is one exciting update or near-term opportunity that you would like to share with the digital health community?
We’re excited to launch our AI-powered resupply and adherence support with several fast-growing sleep and diabetes clinics, reaching tens of thousands of patients this year. Early data shows major reductions in labor costs and therapy dropouts—critical in an industry strained by staffing shortages. We’re also expanding into diabetes resupply and GLP-1 support, creating a unified AI layer across cardiometabolic care. This positions us to serve as the operating system for device-driven chronic care, with direct impact on health equity, outcomes, and reimbursement.
Bio: Morgan Moncada is the CEO and co-founder of Neru Health, which is on a mission to scale sleep and medical device healthcare. Morgan has more than a decade of life science startup experience, managing business development, operations, and product teams at therapeutics and synthetic biology startups. He brings his perspective as a sleep apnea and insomnia patient struggling to access and navigate care to his work at Neru. Morgan received his BS Biology at Stanford and MBA and MS Biotechnology at Harvard.
Org Info: Neru Health is an AI-powered care automation platform helping clinics and medical device suppliers support patients with chronic conditions like sleep apnea and diabetes. Our AI assistant manages patients and clinical/resupply workflows 24/7 to improve diagnosis completion, treatment adherence, and resupply, reducing the need for costly human labor. By bridging fragmented handoffs between primary care, diagnostics, and ongoing therapy, we enable better outcomes for underserved and overlooked patients. Our founders live with these conditions and built Neru to close the care gaps we personally experienced.
What motivated you to pursue your current work? (i.e., What is your “why”?)
I suffered for years with insomnia and sleep apnea, going through multiple diagnostic tests but receiving no follow-up care, no coaching, and no clear path forward. This left me exhausted, anxious, and desperate for solutions. I realized that millions of others—especially shift workers, caregivers, immigrants, and low-income patients—were falling through the same cracks. I started Neru to ensure no one else would have to navigate chronic conditions like sleep apnea or diabetes alone and confused. Our AI platform exists to fill the gaps I personally experienced—providing continuous, compassionate support that extends beyond diagnosis and empowers patients to actually succeed in their care.
What distinct value does your work bring to the digital health field?
Neru delivers end-to-end automation for device-based chronic care—combining AI, behavioral science, and data integration to manage adherence, resupply, and engagement across conditions like sleep apnea and diabetes. Unlike point solutions, we embed directly into DME and clinic workflows, replacing fragmented, manual support systems with 24/7 AI-driven care. Our lived-experience-informed design improves access and outcomes for underserved populations, while unlocking new reimbursement pathways through RTM/RPM codes. Neru’s platform is uniquely positioned to scale personalized care without scaling headcount.
How does your work impact your target end-users or stakeholders?
Our work gives patients with chronic conditions—like sleep apnea, insomnia, and diabetes—24/7 access to personalized support through voice and text AI. We help them overcome common barriers like confusion, stigma, missed follow-ups, and therapy dropouts. For providers and medical device suppliers, we automate high-volume tasks like resupply, coaching, and troubleshooting, reducing staff burden and improving adherence rates. This dual impact improves health outcomes for patients who often feel forgotten, while unlocking new revenue and operational efficiency for our partners. We bring consistency, empathy, and clarity to a care journey that’s often fragmented and overwhelming.
What is one exciting update or near-term opportunity that you would like to share with the digital health community?
We’re excited to launch our AI-powered resupply and adherence support with several fast-growing sleep and diabetes clinics, reaching tens of thousands of patients this year. Early data shows major reductions in labor costs and therapy dropouts—critical in an industry strained by staffing shortages. We’re also expanding into diabetes resupply and GLP-1 support, creating a unified AI layer across cardiometabolic care. This positions us to serve as the operating system for device-driven chronic care, with direct impact on health equity, outcomes, and reimbursement.